Evidence map›Paper›PMID 40934147›Full record

ArticleScience progress

Contrast-induced encephalopathy following endovascular treatment of intracranial aneurysms.

Kishore Balasubramanian, Mohammed Hussain, Hakeem J Shakir

Abstract readCase Reports
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kishore BalasubramanianDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.ORCID 0000-0002-7271-7022
Mohammed HussainDepartment of Neurointerventional Surgery, Wesley Medical Center, Wichita, KS, USA.
Hakeem J ShakirDepartment of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contrast-induced encephalopathy (CIE) is a rare but potentially serious complication that can occur after endovascular procedures involving iodinated contrast media. This report describes two cases of CIE following elective treatment of intracranial aneurysms. The first case involved patients in their 70s patient with multiple comorbidities who developed neurological symptoms, including right gaze preference, left hemibody incoordination, and diffuse right cerebral hemispheric edema, after receiving a flow-diverting stent. The second case was a patient in their late 70s with a history of subarachnoid hemorrhage who experienced progressive encephalopathy after coil embolization, despite initially normal imaging findings. Both patients were managed with supportive care, including anticonvulsants and aggressive fluid management, and both showed significant neurological improvement within days. These cases highlight the diagnostic challenges of CIE, as imaging findings may vary, and underscore the need for clinicians to maintain a high index of suspicion, particularly in patients with risk factors such as advanced age, hypertension, and prior cerebrovascular events. Early recognition, prompt supportive management, and close monitoring are essential. Importantly, CIE can occur even with the use of modern, low-osmolar contrast agents like Isovue-300, emphasizing the need for continued vigilance and further research into prevention and risk factor identification.

Indexed as

Brain DiseasesContrast MediaEndovascular ProceduresIntracranial AneurysmAgedEmbolization, TherapeuticFemaleHumansMaleContrast MediaaneurysmContrast-induced encephalopathyendovascularIsovue-300risk factors

Identifiers

PMID40934147
PMCPMC12426384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.